| 词条 | NeoGenomics |
| 释义 |
| name = NeoGenomics Laboratories, Inc. | logo = | type = Public | traded_as = {{nasdaq|NEO}} Russell 2000 Component | genre = | foundation = 2002 | founder = | location_city = Fort Myers, Florida | location_country = United States | location = | locations = | area_served = Worldwide | key_people = Douglas M. VanOort (Chairman and CEO) | industry = Biotechnology, Health care | products = | services = | revenue = | operating_income = | net_income = | assets = | equity = | owner = | num_employees =1000 (2017) | parent = | divisions = | subsid = | homepage = {{url|NeoGenomics.com}} | footnotes = | intl = }}NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is a high-complexity CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.[1] Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas.[2] HistoryNeoGenomics first received state and national-level laboratory certifications in 2002. 3 years later in 2005, the company developed a technical-only service model using FISH. In 2013, the company launched its sequencing platform[3] and was listed on the Nasdaq Stock Market as NEO. In 2014, NeoGenomics launched molecular tests including BTK and CALR mutation analysis.[4][5] In 2015, NeoGenomics acquired Clarient, Inc. and its subsidiary company, Clarient Diagnostic Services, Inc. , a national cancer diagnostics laboratory with capabilities in immunohistochemistry for solid tumor cancers from GE Healthcare.[6][7] Clarient is headquartered in Aliso Viejo, California; with an ancillary laboratory in Houston, Texas.[8] In November 2017, NeoGenomics established their first headquarters outside the United States in Rolle, Switzerland.[9] References1. ^{{cite web|title=Standardizing Biomarker Analysis Across Clinical Testing|url=https://www.technologynetworks.com/informatics/news/standardizing-biomarker-analysis-across-clinical-testing-287229|website=Technology Networks|accessdate=8 October 2017}} 2. ^{{cite web|last1=Hogan|first1=Dick|title=Fort Myers company buys cancer test provider for $275M|url=http://www.news-press.com/story/news/2015/10/21/neogenomics-buys-cancer-test-provider-clarient-275-million/74351284/|website=The News-Press|accessdate=8 October 2017|language=en}} 3. ^{{cite web|last1=Mansell|first1=Peter|title=Covance, NeoGenomics ally on CT testing services|url=http://www.pharmatimes.com/news/covance,_neogenomics_ally_on_ct_testing_services_1006034|website=PharmaTimes|accessdate=8 October 2017|language=en|date=19 November 2013}} 4. ^{{cite web|title=NeoGenomics Launches Two New Cancer Tests|url=http://www.fdanews.com/articles/174388|website=FDAnews|accessdate=8 October 2017}} 5. ^{{cite web|title=Lee-based NeoGenomics cancer research company acquires California lab|url=http://archive.naplesnews.com/business/lee-based-neogenomics-cancer-research-company-acquires-california-lab-ep-487501211-330738651.html/|publisher=Naples Daily News|accessdate=8 October 2017|language=en}} 6. ^{{cite web|last1=Wasserman|first1=Robert|title=NeoGenomics deal with GE's Clarient 6 months later: boom or bust?|url=https://www.thestreet.com/story/13629429/1/neogenomics-deal-with-ge-s-clarient-6-months-later-boom-or-bust.html|website=TheStreet|accessdate=8 October 2017|date=6 July 2016}} 7. ^{{cite web|last1=Stynes|first1=Tess|title=NeoGenomics to Acquire GE Cancer Testing Unit Clarient|url=https://www.wsj.com/articles/neogenomics-to-acquire-ge-cancer-testing-unit-clarient-1445431725|website=Wall Street Journal|accessdate=8 October 2017|date=21 October 2015}} 8. ^{{cite web|last1=Lawrence|first1=Stacy|title=Small cap NeoGenomics to buy GE cancer diagnostics biz Clarient for $300M|url=http://www.fiercebiotech.com/medical-devices/small-cap-neogenomics-to-buy-ge-cancer-diagnostics-biz-clarient-for-300m|website=FierceBiotech|accessdate=8 October 2017|language=en}} 9. ^{{cite web|last1=Nikolic|first1=Dejan|title=L’américain NeoGenomics installe son siège européen à Rolle|url=https://www.letemps.ch/economie/2017/06/08/lamericain-neogenomics-installe-siege-europeen-rolle|website=Le Temps|accessdate=8 October 2017|language=fr}} External links
3 : Pharmaceutical companies of the United States|Biotechnology companies of the United States|Biotechnology companies established in 2002 |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。